Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine
ML BARBOUR, R BOOY, DWM CROOK… - The Pediatric …, 1993 - journals.lww.com
Late in 1991, before the implementation of a national immunization program against
Haemophilus influenzae type b (Hib) in the United Kingdom, we performed a 4-year follow …
Haemophilus influenzae type b (Hib) in the United Kingdom, we performed a 4-year follow …
Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow …
SB Black, HR Shinefield - The Pediatric infectious disease journal, 1992 - europepmc.org
Between February, 1988, and June, 1990, the safety, immunogenicity and efficacy of the
HbOC (oligosaccharide conjugate Haemophilus influenza type b) vaccine was evaluated in …
HbOC (oligosaccharide conjugate Haemophilus influenza type b) vaccine was evaluated in …
Clinical Comparison of the Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid and the Oligosaccharide–CRM197 Protein Vaccines in Infancy
H Peltola, J Eskola, H Käyhty, AK Takala… - Archives of pediatrics …, 1994 - jamanetwork.com
Objective: To compare twoHaemophilus influenzaetype B (HiB) conjugate vaccines, a
polysaccharide–diphtheria toxoid conjugate (PRP-D) vaccine and an oligosaccharide–CRM …
polysaccharide–diphtheria toxoid conjugate (PRP-D) vaccine and an oligosaccharide–CRM …
Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate …
HR Shinefield, S Black - The Pediatric infectious disease journal, 1995 - journals.lww.com
Haemophilus influenzae type b (Hib) oligosaccharide CRM 197 (HbOC-HibTITER®, Lederle-
Praxis) conjugate vaccine was approved for use in infants in October, 1990, as a result of an …
Praxis) conjugate vaccine was approved for use in infants in October, 1990, as a result of an …
Haemophilus influenzae type b vaccines: history, choice and comparisons
MD Decker, KM Edwards - The Pediatric infectious disease journal, 1998 - journals.lww.com
The conjugate Haemophilus influenzae type b (Hib) vaccines are safe and far more
immunogenic among infants and young children than is the unconjugated H. influenzae type …
immunogenic among infants and young children than is the unconjugated H. influenzae type …
Disease Caused by Haemophilus influenzae Type b in the Immediate Period After Homologous Immunization: Immunologic Investigation
SK Sood, RS Daum - Pediatrics, 1990 - publications.aap.org
Several Haemophilus influenzae type b vaccines have been licensed and recommended for
administration to children in the United States. These vaccines have consisted of purified …
administration to children in the United States. These vaccines have consisted of purified …
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children
SB BLACK, HR SHINEFIELD, B Fireman… - The Pediatric …, 1991 - journals.lww.com
The efficacy of the HbOC conjugate Haemophilus influenzae type b vaccine was evaluated
in a study population of 61 080 infants in the Northern California Kaiser Permanente Medical …
in a study population of 61 080 infants in the Northern California Kaiser Permanente Medical …
Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines
JC MOHLE-BOETANI, G AJELLO… - The Pediatric …, 1993 - journals.lww.com
Rates of invasive Haemophilus influenzae type b (Hib) disease in children decreased very
rapidly after licensure of Hib conjugate vaccines. A role for a vaccine-related reduction in …
rapidly after licensure of Hib conjugate vaccines. A role for a vaccine-related reduction in …
Response of 7-to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines
EP Rothstein, RP Schiller, JAC Girone… - American Journal of …, 1991 - jamanetwork.com
• Objective.—To evaluate the immunologie potential of infants 7 to 15 months of age to
respond toHaemophilus influenzaetype b polysaccharide vaccine following immunization …
respond toHaemophilus influenzaetype b polysaccharide vaccine following immunization …
[HTML][HTML] A Randomized, Prospective Field Trial of a Conjugate Vaccine in the Protection of Infants and Young Children against Invasive Haemophilus influenzae Type …
J Eskola, H Käyhty, AK Takala, H Peltola… - … England Journal of …, 1990 - Mass Medical Soc
Background. Haemophilus influenzae type b is the leading cause of invasive bacterial
disease in young children. The capsular polysaccharide vaccine does not protect children at …
disease in young children. The capsular polysaccharide vaccine does not protect children at …